Thalidomide: an experience in therapeutic outcome and adverse reactions.

  title={Thalidomide: an experience in therapeutic outcome and adverse reactions.},
  author={Nand Lal Sharma and Vikas Chander Sharma and Vikram K Mahajan and Vinay Shanker and Nitin Ranjan and Mudita Gupta},
  journal={The Journal of dermatological treatment},
  volume={18 6},
BACKGROUND The US FDA-approved thalidomide for the treatment of chronic recurrent/severe erythema nodosum leprosum. Thalidomide is also useful in many other inflammatory dermatological conditions where patients have exhausted other treatment options. METHODS The beneficial and adverse clinical effects of thalidomide were studied in 25 patients suffering… CONTINUE READING